Literature DB >> 1321773

Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis.

K Tarao1, A Shimizu, S Ohkawa, M Harada, Y Ito, S Tamai, Y Kuni, N Okamoto, T Inoue, M Kanisawa.   

Abstract

The relationship between DNA synthesis activity in hepatocytes from cirrhotic tissue and development of hepatocellular carcinoma was studied in 33 posthepatitic patients with Child's grade A cirrhosis. DNA synthesis activity was measured by a bromodeoxyuridine (a thymidine analogue) labeling index, using the bromodeoxyuridine-antibromodeoxyuridine in vitro method, and the patients were followed up prospectively with frequent liver ultrasonography for 2 years. During the 2-year follow-up, 11 of the 33 cirrhotic patients developed hepatocellular carcinoma; they included 8 of the 15 patients (53%) in the high labeling index (greater than 1.5%) group compared with only 3 of the 18 patients (17%) in the low labeling index (less than 1.5) group (P less than 0.05). Five of the latter 18 subsequently had increased synthesis activity. Of these 20 patients who showed high synthesis activities either initially or subsequently, 10 (50%) developed hepatocellular carcinoma, in contrast to 1 of 13 (8%) with persistently low activities (P less than 0.05). Thus, hepatocellular carcinoma seems to develop or may become detectable when DNA synthesis in the background cirrhosis is increasing or remains high.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321773     DOI: 10.1016/0016-5085(92)90852-p

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

2.  Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis.

Authors:  S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.

Authors:  Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisanaga; Akira Kanamori; Toshifumi Tada; Junko Tanaka; Hiroshi Yoshizawa
Journal:  J Gastroenterol       Date:  2010-12-07       Impact factor: 7.527

4.  Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis.

Authors:  L Bolondi; L Gramantieri; P Chieco; C Melchiorri; D Treré; B Stecca; M Derenzini; L Barbara
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

5.  Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.

Authors:  M Borzio; D Trerè; F Borzio; A R Ferrari; S Bruno; M Roncalli; G Colloredo; G Leandro; F Oliveri; M Derenzini
Journal:  Mol Pathol       Date:  1998-04

6.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 7.  Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis.

Authors:  Nikolaos P Karidis; Ioanna Delladetsima; Stamatios Theocharis
Journal:  Gastroenterol Res Pract       Date:  2015-03-29       Impact factor: 2.260

8.  Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.

Authors:  K Tarao; H Hoshino; A Shimizu; S Ohkawa; Y Nakamura; M Harada; Y Ito; S Tamai; M Akaike; Y Sugimasa
Journal:  Jpn J Cancer Res       Date:  1994-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.